Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023 20 januari 2023 News Veterinary Medicines Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines 20 januari 2023 News Human Medicines Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 januari 2023 News Human Veterinary Medicines Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 januari 2023 News Human Clinical trials Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 januari 2023 News Human Pharmacovigilance Referrals EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 januari 2023 News Human Referrals End-of-year message from EMA’s Executive Director 21 december 2022 News Corporate EMA business hours over holiday period 20 december 2022 News Corporate COVID-19 Facilitating Decentralised Clinical Trials in the EU 19 december 2022 News Human Clinical trials EMA Management Board: highlights of December 2022 meeting 16 december 2022 News Corporate 1 … 30 31 32 33 34 Page 34 of 379 35 36 37 38 … 379
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023 20 januari 2023 News Veterinary Medicines
Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines 20 januari 2023 News Human Medicines
Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 januari 2023 News Human Veterinary Medicines
Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 januari 2023 News Human Clinical trials
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 januari 2023 News Human Pharmacovigilance Referrals
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 januari 2023 News Human Referrals